Mostrando 4 resultados de: 4
Subtipo de publicación
Article(4)
Publisher
American Heart Journal(1)
European Heart Journal - Quality of Care and Clinical Outcomes(1)
New England Journal of Medicine(1)
Nutrition, Metabolism and Cardiovascular Diseases(1)
Vitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial
ArticleAbstract: Background and aims: Vitamin D has mostly been tested in Western populations. We examined the effectPalabras claves:Cáncer, Cardiovascular disease, death, Falls, fractures, vitamin DAutores:Bosch J., Christou C., Dagenais G.R., Dans A.M., Gamra H., Gao P., Joseph P.G., Pais P., PATRICIO LOPEZ -JARAMILLO, Santoso A., Talukder S.H., Teo K., Tyrwhitt J., Xavier D., Yusoff K., Yusuf S.Fuentes:googlescopusPolypill with or without aspirin in persons without cardiovascular disease
ArticleAbstract: BACKGROUND A polypill comprising statins, multiple blood-pressure-lowering drugs, and aspirin has bePalabras claves:Autores:Bosch J.J., Christou C., Dagenais G.R., Dans A.M., Gamra H., Gao P., Girish P., Joseph P.G., McCready T., Pais P., PATRICIO LOPEZ -JARAMILLO, Rocha C., Santoso A., Talukder S.H., Teo K.K., Tyrwhitt J., Xavier D., Xavier F., Yeates K.E., Yusoff K., Yusuf S.Fuentes:googlescopusThe International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct
ArticleAbstract: Background: It is hypothesized that in individuals without clinical cardiovascular disease (CVD), buPalabras claves:Autores:Bosch J.J., Dans A.M., Gamra H., Gao P., Joseph P.G., Lopez P.C., Pais P., PATRICIO LOPEZ -JARAMILLO, Santoso A., Talukder S.H., Teo K.K., Tyrwhitt J., Xavier D., Yeates K.E., Yusoff K., Yusuf S.Fuentes:googlescopusThe cost implications of a polypill for primary prevention in the TIPS-3 trial
ArticleAbstract: Aims The International Polycap Study 3 (TIPS-3) trial demonstrated that a polypill containing cholesPalabras claves:Cardiovascular disease, cost analysis, Polypill, Primary PreventionAutores:Dans A.L., Gamra H., Gao P., Joseph P.G., Lamy A., Pais P., PATRICIO LOPEZ -JARAMILLO, Santoso A., Talukder S.H., Tong W., Walli-Attaei M., Xavier D., Yusuf S.Fuentes:googlescopus